InMode Return on Tangible Equity 2018-2025 | INMD
Current and historical return on tangible equity values for InMode (INMD) over the last 10 years. Return on tangible equity can be defined as the amount of net income returned as a percentage of shareholders equity, after subtracting intangible assets, goodwill and preferred equity.
| InMode Return On Tangible Equity Historical Data | |||
|---|---|---|---|
| Date | TTM Net Income | Tangible Equity | Return on Tangible Equity |
| 2025-06-30 | $0.18B | $0.63B | 26.64% |
| 2025-03-31 | $0.18B | $0.62B | 25.04% |
| 2024-12-31 | $0.18B | $0.70B | 24.21% |
| 2024-09-30 | $0.15B | $0.74B | 19.94% |
| 2024-06-30 | $0.15B | $0.75B | 19.51% |
| 2024-03-31 | $0.18B | $0.82B | 24.34% |
| 2023-12-31 | $0.20B | $0.79B | 28.64% |
| 2023-09-30 | $0.18B | $0.72B | 28.58% |
| 2023-06-30 | $0.18B | $0.67B | 31.56% |
| 2023-03-31 | $0.17B | $0.60B | 32.47% |
| 2022-12-31 | $0.16B | $0.56B | 33.77% |
| 2022-09-30 | $0.18B | $0.51B | 39.78% |
| 2022-06-30 | $0.17B | $0.45B | 41.79% |
| 2022-03-31 | $0.17B | $0.40B | 44.33% |
| 2021-12-31 | $0.17B | $0.42B | 46.60% |
| 2021-09-30 | $0.15B | $0.38B | 47.15% |
| 2021-06-30 | $0.13B | $0.33B | 46.04% |
| 2021-03-31 | $0.10B | $0.29B | 38.95% |
| 2020-12-31 | $0.08B | $0.26B | 33.82% |
| 2020-09-30 | $0.06B | $0.23B | 28.57% |
| 2020-06-30 | $0.05B | $0.21B | 27.03% |
| 2020-03-31 | $0.06B | $0.20B | 37.56% |
| 2019-12-31 | $0.06B | $0.18B | 52.25% |
| 2019-09-30 | $0.04B | $0.16B | 50.60% |
| 2019-06-30 | $0.04B | $0.07B | 81.40% |
| 2019-03-31 | $0.03B | $0.06B | 108.00% |
| 2018-12-31 | $0.02B | $0.05B | 204.44% |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Products Manufacturing | $0.899B | $0.395B |
| InMode Ltd. is a provider of medical technologies. It develops, manufactures and markets devices harnessing novel radio-frequency technology. The company serves plastic surgery, gynecology, dermatology, otolaryngology and ophthalmology. InMode Ltd. is based in Yokneam, Israel. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Abbott Laboratories (ABT) | United States | $228.035B | 26.74 |
| Boston Scientific (BSX) | United States | $152.087B | 36.27 |
| Stryker (SYK) | United States | $143.981B | 29.31 |
| EssilorLuxottica (ESLOY) | France | $137.519B | 0.00 |
| Medtronic (MDT) | Ireland | $118.029B | 16.74 |
| Lonza Group Ag (LZAGY) | Switzerland | $47.517B | 0.00 |
| Haleon (HLN) | United Kingdom | $43.032B | 24.56 |
| ResMed (RMD) | United States | $41.478B | 29.66 |
| GE HealthCare Technologies (GEHC) | United States | $33.973B | 15.97 |
| Agilent Technologies (A) | United States | $33.326B | 21.73 |
| Terumo (TRUMY) | Japan | $27.583B | 32.68 |
| Koninklijke Philips (PHG) | Netherlands | $25.989B | 17.19 |
| Insulet (PODD) | United States | $21.796B | 73.03 |
| Zimmer Biomet Holdings (ZBH) | United States | $20.170B | 12.84 |
| Smith & Nephew SNATS (SNN) | United Kingdom | $15.868B | 0.00 |
| Baxter (BAX) | United States | $12.317B | 9.52 |
| Sunny Optical Technology (SNPTF) | China | $10.800B | 0.00 |
| Demant (WILYY) | Denmark | $8.240B | 0.00 |
| Bio-Rad Laboratories (BIO) | United States | $7.436B | 27.31 |
| Lantheus Holdings (LNTH) | United States | $3.665B | 9.91 |
| Envista Holdings (NVST) | United States | $3.472B | 24.29 |
| Shandong Weigao Medical Polymer (SHWGF) | China | $3.459B | 0.00 |
| Prestige Consumer Healthcare (PBH) | United States | $3.214B | 14.26 |
| Perrigo (PRGO) | Ireland | $3.174B | 7.93 |
| ICU Medical (ICUI) | United States | $2.723B | 18.54 |
| Haemonetics (HAE) | United States | $2.516B | 11.23 |
| LeMaitre Vascular (LMAT) | United States | $2.137B | 45.82 |
| Curaleaf Holdings (CURLF) | Canada | $1.824B | 0.00 |
| AtriCure (ATRC) | United States | $1.781B | 0.00 |
| Green Thumb Industries (GTBIF) | United States | $1.732B | 74.36 |
| QuidelOrtho (QDEL) | United States | $1.710B | 10.77 |
| AdaptHealth (AHCO) | United States | $1.287B | 18.35 |
| Phibro Animal Health (PAHC) | United States | $1.203B | 15.38 |
| BioLife Solutions (BLFS) | United States | $1.153B | 2406.00 |
| Acuren (TIC) | United States | $1.142B | 0.00 |
| Neogen (NEOG) | United States | $1.136B | 18.03 |
| Tilray Brands (TLRY) | Canada | $1.046B | 0.00 |
| Valneva SE (VALN) | France | $0.800B | 0.00 |
| Kestra Medical Technologies (KMTS) | United States | $0.772B | 0.00 |
| Maravai LifeSciences Holdings (MRVI) | United States | $0.685B | 0.00 |
| Surmodics (SRDX) | United States | $0.542B | 0.00 |
| ZimVie (ZIMV) | United States | $0.532B | 20.49 |
| SNDL (SNDL) | Canada | $0.531B | 0.00 |
| Cresco Labs (CRLBF) | United States | $0.511B | 0.00 |
| Verano Holdings (VRNOF) | United States | $0.465B | 0.00 |
| VAREX IMAGING (VREX) | United States | $0.439B | 15.10 |
| CeriBell (CBLL) | United States | $0.429B | 0.00 |
| Owens & Minor (OMI) | United States | $0.423B | 3.75 |
| Evolus (EOLS) | United States | $0.414B | 0.00 |
| Capricor Therapeutics (CAPR) | United States | $0.368B | 0.00 |
| Sanuwave Health (SNWV) | United States | $0.357B | 0.00 |
| SEMPERIT AG HLD (SEIGY) | Austria | $0.330B | 0.00 |
| Canopy Growth (CGC) | Canada | $0.318B | 0.00 |
| Aurora Cannabis (ACB) | Canada | $0.298B | 0.00 |
| Viemed Healthcare (VMD) | United States | $0.289B | 21.88 |
| Omeros (OMER) | United States | $0.258B | 0.00 |
| Cerus (CERS) | United States | $0.247B | 0.00 |
| Sanara MedTech (SMTI) | United States | $0.244B | 0.00 |
| Vireo Growth (VREOF) | United States | $0.238B | 0.00 |
| TerrAscend (TSNDF) | Canada | $0.233B | 0.00 |
| Brainsway (BWAY) | Israel | $0.230B | 60.95 |
| Quanterix (QTRX) | United States | $0.221B | 0.00 |
| Organigram Global (OGI) | Canada | $0.213B | 0.00 |
| Exagen (XGN) | United States | $0.210B | 0.00 |
| OraSure Technologies (OSUR) | United States | $0.205B | 0.00 |
| High Tide (HITI) | Canada | $0.192B | 0.00 |
| Utah Medical Products (UTMD) | United States | $0.187B | 15.40 |
| Biote (BTMD) | United States | $0.158B | 4.74 |
| FitLife Brands (FTLF) | United States | $0.158B | 19.40 |
| TriSalus Life Sciences (TLSI) | United States | $0.138B | 0.00 |
| Jushi Holdings (JUSHF) | United States | $0.136B | 0.00 |
| Jin Medical (ZJYL) | China | $0.100B | 0.00 |
| Fonar (FONR) | United States | $0.094B | 12.09 |
| MacroGenics (MGNX) | United States | $0.093B | 0.00 |
| Quipt Home Medical (QIPT) | United States | $0.086B | 0.00 |
| Oramed Pharmaceuticals (ORMP) | United States | $0.086B | 0.00 |
| Apyx Medical (APYX) | United States | $0.085B | 0.00 |
| Agape ATP (ATPC) | $0.069B | 0.00 | |
| Cytosorbents (CTSO) | United States | $0.067B | 0.00 |
| ImmuCell (ICCC) | United States | $0.060B | 0.00 |
| Safety Shot (SHOT) | United States | $0.054B | 0.00 |
| Zynex (ZYXI) | United States | $0.048B | 0.00 |
| Veru (VERU) | United States | $0.046B | 0.00 |
| Nephros (NEPH) | United States | $0.045B | 35.50 |
| Modular Medical (MODD) | United States | $0.039B | 0.00 |
| United-Guardian (UG) | United States | $0.037B | 14.38 |
| Rockwell Medical (RMTI) | United States | $0.033B | 0.00 |
| Trinity Biotech (TRIB) | Ireland | $0.020B | 0.00 |
| Allurion Technologies (ALUR) | United States | $0.019B | 0.00 |
| INLIF (INLF) | $0.017B | 0.00 | |
| Meihua Medical Technologies (MHUA) | China | $0.012B | 0.00 |
| IM Cannabis (IMCC) | Canada | $0.011B | 0.00 |
| Senestech (SNES) | United States | $0.010B | 0.00 |
| Flora Growth (FLGC) | United States | $0.010B | 0.00 |
| Innovative Eyewear (LUCY) | United States | $0.009B | 0.00 |
| Cellectar Biosciences (CLRB) | United States | $0.008B | 0.00 |
| Sharps Technology (STSS) | United States | $0.006B | 0.00 |
| GlucoTrack (GCTK) | United States | $0.003B | 0.00 |
| Akanda (AKAN) | Canada | $0.002B | 0.00 |
| InterCure (INCR) | Israel | $0.000B | 0.00 |
| InVivo Therapeutics Holdings (NVIVQ) | United States | $0.000B | 0.00 |